Quick Answer
BioLineRx Ltd. reported Total Assets of $40.91 million for the year ending 2025.
- BioLineRx Ltd. showed an increase of +5.1% in Total Assets from 2024 to 2025.
- This data is from BioLineRx Ltd.'s annual report (Form 10-K), filed with the SEC on March 23, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 10 years of available data (2016 to 2025), BioLineRx Ltd.'s Total Assets has grown by 5.0%.
- Historical annual values: Fiscal year 2025: $40.91 million | Fiscal year 2024: $38.91 million | Fiscal year 2023: $63.93 million | Fiscal year 2022: $76.38 million | Fiscal year 2021: $81.39 million | Fiscal year 2020: $47.29 million | Fiscal year 2019: $53.57 million | Fiscal year 2018: $56.23 million | Fiscal year 2017: $60.97 million | Fiscal year 2016: $38.94 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: